Brief: Biora Therapeutics Approved Reverse Stock Split
Oct 11 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS - APPROVED REVERSE STOCK SPLIT OF CO'S
COMMON STOCK, PAR VALUE $0.001 PER SHARE AT RATIO OF 10:1
* BIORA THERAPEUTICS INC - APPROVED REDUCTION IN TOTAL
NUMBER OF
AUTHORIZED SHARES OF COMMON STOCK FROM 300 MILLION SHARES TO 255
MILLION SHARES
* BIORA THERAPEUTICS INC - REVERSE STOCK SPLIT EFFECTIVE ON
OCTOBER 18
Source text for Eikon: ID:n0000950170-24-114214
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules